EKF Diagnostics (LON:EKF) Shares Down 7.4% - Here's Why

Shares of EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) were down 7.4% on Friday . The company traded as low as GBX 25 ($0.34) and last traded at GBX 25 ($0.34). Approximately 166,070 shares traded hands during trading, a decline of 66% from the average daily volume of 483,755 shares. The stock had previously closed at GBX 27 ($0.36).

EKF Diagnostics Stock Up 1.8%

The stock has a fifty day simple moving average of GBX 22.20 and a two-hundred day simple moving average of GBX 23.81. The firm has a market cap of £114.67 million, a PE ratio of 24.01 and a beta of 0.57. The company has a current ratio of 4.60, a quick ratio of 1.77 and a debt-to-equity ratio of 0.34.

EKF Diagnostics (LON:EKF - Get Free Report) last posted its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. As a group, sell-side analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

Insider Activity

In related news, insider Gavin T. Jones acquired 50,000 shares of the stock in a transaction dated Tuesday, March 25th. The shares were purchased at an average price of GBX 22 ($0.30) per share, for a total transaction of £11,000 ($14,864.86). Corporate insiders own 5.24% of the company's stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.